Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Beta Keto Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1109018C details a Lewis acid-catalyzed route to pyridazinones. Offers cost reduction and scalable continuous processing for agrochemical intermediates.
Patent CN102964415B details a high-yield synthesis of 3beta-hydroxy-5-pregnene-20-ketone, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108976186B details a copper-catalyzed C-H activation route for tetra-substituted furans, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113121338A reveals a green photocatalytic method for alpha-hydroxylation using air and visible light, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110872232B reveals a novel phase transfer catalysis method for synthesizing chiral alpha-difluoromethyl-beta-keto esters, offering significant cost reduction and scalability for API manufacturing.
Patent CN1308309C reveals a one-pot Blaise reaction for beta-ketoesters. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN115160162A details an iridium-catalyzed method for synthesizing chiral beta-hydroxy alpha-amino acid derivatives with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN110483290B details a green CuI-catalyzed route for beta-keto esters, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel copper-catalyzed asymmetric propargyl substitution method ensures high ee and scalable production for pharmaceutical intermediates.
Patent CN115160162B reveals high-efficiency chiral synthesis. Delivers superior purity and scalable supply chain solutions for global pharmaceutical intermediate manufacturing.
Novel zirconium catalyst method for chiral alpha-hydroxy-beta-keto esters. High yield, excellent ee, cost-effective industrial scale-up for pharmaceutical intermediates.
Discover how large steric hindrance chiral quaternary ammonium salt catalysts boost enantioselectivity in alpha-hydroxy-beta-keto ester synthesis, reducing production costs and supply chain risks for pharmaceutical manufacturers.
Solve low enantioselectivity in alpha-hydroxy-beta-keto ester synthesis. Our CDMO expertise scales this patent-protected catalyst for 87% ee, reducing R&D costs and supply chain risks. Contact for custom synthesis.
97% ee, >95% yield, low-cost industrial production of chiral alpha-hydroxy-beta-keto esters for agrochemicals. Solve supply chain risks with scalable zirconium catalysis.
Boost enantioselectivity in alpha-hydroxy-beta-keto ester synthesis with our large steric hindrance catalysts. Reduce costs, ensure GMP compliance, and scale efficiently. Contact us for custom synthesis.
Solve low enantioselectivity & high catalyst cost in alpha-hydroxy-beta-keto ester production. 97% ee, 95% yield, 5-25 mol% catalyst. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.